Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s share price crossed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of C$4.99 and traded as high as C$5.12. Medexus Pharmaceuticals shares last traded at C$5.12, with a volume of 83,240 shares.
Medexus Pharmaceuticals Stock Up 4.1%
The company has a fifty day moving average of C$4.99 and a two-hundred day moving average of C$4.21. The stock has a market capitalization of C$160.90 million, a price-to-earnings ratio of -73.14 and a beta of 0.12.
Medexus Pharmaceuticals Company Profile
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
